Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective

Figures & data

Table 1 Target phosphorous levels in patients with chronic kidney disease (CKD)

CKD stage	Target phosphorous levels
Stages three and four	2.7–4.6 mg/dL
Stage five	3.5–5.5 mg/dL

Figure 1 Algorithm for choice of phosphate binder.

Figure 2 Patient survival on hemodialysis among a retrospective cohort from South India.

Table 2 Cost of phosphate binders in India

Brand name	Price
Calcium acetate 400 mg	$0.32
Calcium acetate 800 mg	$0.60
Calcium carbonate 500 mg	$0.08
Sevelamer carbonate 800 mg	$0.63
Sevelamer carbonate 400 mg	$0.37
Lanthanum carbonate 250 mg	$0.18
Lanthanum carbonate 500 mg	$0.37
Cinacalcet 30 mg	$1.08
Alpha calcidol 0.25 μg	$0.13
Alpha calcidol 0.5 μg	$0.16
Alpha calcidol 1 μg	$0.40